Fusion of Labia Minora SIR,-I was interested in reading about Dr. C. J. Carr's description of a case of fusion of the labia minora (July 29, p. 314), because a similar case was recently admitted to the gynaecological department of this hospital.
The patient was a 53-year-old, spinster who was admitted on July 27 of this year. She gave a history of difficulty in passing urine for the past two years, and a yellow offensive vaginal discharge for the past two months. She had previously had a subtotal hysterectomy at another hospital in 1937. There were, however, no details of the findings at this operation, since the records did not go back that far.
Subsequent exploration under anaesthesia revealed, likewise, an almost complete fusion of the labia minora, with a very small opening anteriorly common to both urethra and vagina. The labia were divided and a normal vagina and cervical stump were found. A bladder sound was also passed without difficulty. Later a cultural examination of the urine revealed a heavy growth of Escherichia coli, and a high vaginal swab-culture revealed a heavy growth of Escherichia coli and P-haemolytic streptococci of Lancefield's group C. Drug-sensitivity tests showed that these responded to sulphadimidine, and she was given a five-day course of this and then discharged home. One therefore concludes that this was a case of cicatrizing stenosis of the labia minora secondary to infection. Patients with Trophoblast Tumours Wanted SIR,-We are writing to ask for assistance in a clinical test to determine the possible efficacy of 6-azauridine (AzUR) in the treatment of trophoblast tumours. - We have recently reported that AzUR given orally is an effective ovicide in the mouse,' terminating early pregnancy at dosage levels which produce no detectable toxic effect in the maternal organism. We have found that the first effect of the drug on the foetus is to reduce its rate of growth, and to produce a relatively structureless mole. Later, there is autolysis, beginning at the centre of the mole, rapidly progressing to the periphery, and eventually including the placenta. Within a few days of the onset of lysis, the products of conception are entirely resorbed and normal oestrus periodicity is resumed. Whilst we do not yet know the effect of AzUR on 'the human ovum, we do know that it is without toxic effect in human subjects in doses which, by analogy with the mouse, might be expected to be ovicidal. Thus, it has been given in doses of 300 mg. per kg. body weight daily for several weeks in leukaemia, without any of the adverse effects commonly produced by cytotoxic and cytostatic agents such as mercaptopurine and folic-acid antagonists.
Supplies of AzUR are limited by the difficulty of preparation. Moreover, we have found that different batches vary somewhat in activity, and there is no necessary relationship between their ovicidal activity and their toxicity. However, the Distillers Company (Biochemicals) Ltd. have undertaken to supply AzUR in amounts which, though limited, will be sufficient to determine its activity against trophoblast tumours. Each batch will be prepared in aqueous solution for intravenous use, and will then be tested in mice both for ovicidal activity and toxicity.
It is proposed that suitable batches of AzUR shall be available at the Highlands Hospital for use on patients under the care of Mr. David Savage. It is hoped that physicians and surgeons will refer cases of trophoblast tumours, especially chorion carcinoma, so that they may be considered for inclusion in the trial. The limit to the numbers will be determined by the amount of AzUR available, and it is hoped that this will become sufficient for the inclusion, later, of some cases of hydatiform mole. Inquiries concerning admission should be addressed to David Savage, F.R.C.S., Highlands From a group of over 500 patients under treatment for rheumatoid arthritis in a predominantly steroid clinic at the Dudley Road Hospital, Birmingham, 26 cases were selected at random from those who were stabilized on an oral maintenance dose of corticosteroid (prednisolone, triamcinolone, methylprednisolone, or dexamethasone). Betamethasone (" betnelan ") was substituted on a tablet-for-
